167 related articles for article (PubMed ID: 17103336)
1. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Pharm Res; 2007 Jan; 24(1):125-35. PubMed ID: 17103336
[TBL] [Abstract][Full Text] [Related]
2. Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation.
Rogueda PG; Price R; Smith T; Young PM; Traini D
J Colloid Interface Sci; 2011 Sep; 361(2):649-55. PubMed ID: 21714970
[TBL] [Abstract][Full Text] [Related]
3. Surface energy and interparticle forces correlations in model pMDI formulations.
Traini D; Rogueda P; Young P; Price R
Pharm Res; 2005 May; 22(5):816-25. PubMed ID: 15906178
[TBL] [Abstract][Full Text] [Related]
4. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy.
Ashayer R; Luckham PF; Manimaaran S; Rogueda P
Eur J Pharm Sci; 2004 Mar; 21(4):533-43. PubMed ID: 14998585
[TBL] [Abstract][Full Text] [Related]
6. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
7. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
D'Sa D; Chan HK; Chrzanowski W
Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
[TBL] [Abstract][Full Text] [Related]
8. Particulate drug interactions with polymeric and elastomeric valve components in suspension formulations for metered dose inhalers.
James J; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2009 Jan; 366(1-2):124-32. PubMed ID: 18835343
[TBL] [Abstract][Full Text] [Related]
9. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
[TBL] [Abstract][Full Text] [Related]
10. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
Chambers F; Ludzik A
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Jones MD; Buckton G
Int J Pharm; 2016 Jul; 509(1-2):419-430. PubMed ID: 27265314
[TBL] [Abstract][Full Text] [Related]
12. Performance of pressurized metered-dose inhalers at extreme temperature conditions.
Morin CMD; Ivey JW; Titosky JTF; Suderman JD; Olfert JS; Vehring R; Finlay WH
J Pharm Sci; 2014 Nov; 103(11):3553-3559. PubMed ID: 25252183
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
14. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
[TBL] [Abstract][Full Text] [Related]
15. A novel apparatus for the determination of solubility in pressurized metered dose inhalers.
Traini D; Young PM; Price R; Rogueda P
Drug Dev Ind Pharm; 2006; 32(10):1159-63. PubMed ID: 17090438
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.
Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
Pharm Res; 2015 Sep; 32(9):2928-36. PubMed ID: 25788449
[TBL] [Abstract][Full Text] [Related]
17. A model for predicting size distributions delivered from pMDIs with suspended drug.
Stein SW; Sheth P; Myrdal PB
Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
[TBL] [Abstract][Full Text] [Related]
18. Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Int J Pharm; 2006 Aug; 320(1-2):58-63. PubMed ID: 16735100
[TBL] [Abstract][Full Text] [Related]
19. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
Jones SA; Martin GP; Brown MB
Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
